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Impact of Telemedicine on Mortality, Length of
Stay, and Cost Among Patients in Progressive Care
Units: Experience From a Large Healthcare System
Donna Lee Armaignac, PhD, APRN CNS-BC, CCNS, CCRN; Anshul Saxena, PhD; Muni Rubens, PhD;
Carlos A. Valle, MSIT; Lisa-Mae S. Williams, MSN; Emir Veledar, PhD; Louis T. Gidel MD, PhD

Objectives: To determine whether Telemedicine intervention can
affect hospital mortality, length of stay, and direct costs for progressive care unit patients.
Design: Retrospective observational.
Setting: Large healthcare system in Florida.
Patients: Adult patients admitted to progressive care unit (PCU)
as their primary admission between December 2011 and August
2016 (n = 16,091).
Interventions: Progressive care unit patients with telemedicine intervention (telemedicine PCU [TPCU]; n = 8091) and without telemedicine control (nontelemedicine PCU [NTPCU]; n = 8000) were
compared concurrently during study period.
Measurements and Main Results: Primary outcome was progressive care unit and hospital mortality. Secondary outcomes were
hospital length of stay, progressive care unit length of stay, and
mean direct costs. The mean age NTPCU and TPCU patients
were 63.4 years (95% CI, 62.9–63.8 yr) and 71.1 years (95% CI,
70.7–71.4 yr), respectively. All Patient Refined-Diagnosis Related
Group Disease Severity (p < 0.0001) and All Patient RefinedDiagnosis Related Group patient Risk of Mortality (p < 0.0001)
scores were significantly higher among TPCU versus NTPCU.
After adjusting for age, sex, race, disease severity, risk of mortality, hospital entity, and organ systems, TPCU survival benefit was
20%. Mean progressive care unit length of stay was lower among
TPCU compared with NTPCU (2.6 vs 3.2 d; p < 0.0001). Postprogressive care unit hospital length of stay was longer for TPCU
patients, compared with NTPCU (7.3 vs 6.8 d; p < 0.0001). The
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overall mean direct cost was higher for TPCU ($13,180), compared with NTPCU ($12,301; p < 0.0001).
Conclusions: Although there are many studies about the effects of
telemedicine in ICU, currently there are no studies on the effects of
telemedicine in progressive care unit settings. Our study showed
that TPCU intervention significantly decreased mortality in progressive care unit and hospital and progressive care unit length of
stay despite the fact patients in TPCU were older and had higher
disease severity, and risk of mortality. Increased postprogressive care unit hospital length of stay and total mean direct costs
inclusive of telemedicine costs coincided with improved survival
rates. Telemedicine intervention decreased overall mortality and
length of stay within progressive care units without substantial
cost incurrences. (Crit Care Med 2018; XX:00–00)
Key Words: direct costs; hospital mortality; length of stay;
progressive care unit; telemedicine

P

atients admitted to hospitals have different disease severity and require different levels of care (1). A large proportion of low risk patients are admitted to ICUs just for
monitoring purposes, thus increasing patient load and affecting functionality of ICUs (2). Similarly, a significant proportion
of patients who require more intensive care are treated in the
wards (3, 4). There is an increasing need for step-down units
such as progressive care units (PCUs) due to diverse population
characteristics, increased proportion of aging patient population, increasing cost of care, and shortage of intensivists (5).
PCUs manage patients who need “intermediate” level of care—
patients who require more extensive care than in general wards,
but less than in ICUs (6). PCUs were created to provide costeffective and high-standard care without negatively impacting
patient outcomes for less severely ill patients who are admitted to ICUs for monitoring or more serious patients who are
treated in the wards (2, 7).
To overcome increasing patient demands and shortage of
intensivists, telemedicine, a relatively new method of care delivery, has been applied to critical care (8, 9). Approximately, 11%
www.ccmjournal.org
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of critical care units in the United States have integrated telemedicine and many have reported positive health outcomes (10).
Telemedicine includes managing patients through monitoring
devices controlled by physicians and nurses in remote locations.
Telemedicine has improved patient outcomes through advanced
monitoring, cognitive affordances, clinical decision-support
functions, execution of life saving, and evidence-based critical
care protocols. In a retrospective study that looked for the effect
of telemedicine on mortality and length of stay (LOS) in community hospital ICUs, it was observed that telemedicine significantly decreased odds of ICU mortality (odds ratio, 0.46; 95%
CI, 0.32–0.66) when compared with pretelemedicine implementation stages (11). In addition, telemedicine also decreased
LOS. Similarly, another study by Lilly et al (10) reported that
hospital mortality rate significantly decreased from 13.6% before
telemedicine implementation to 11.8% after intervention. ICU
mortality also significantly reduced from 10.7% to 8.6% after the
implementation. In a review article on acceptance of telemedicine coverage among ICU staff, it was observed that telemedicine in ICU (Tele-ICU) installations were rapidly accepted by
ICU staff despite initial difficulties in autonomy, training, scrutiny, and malfunctions, primarily due to perceived benefits for
patients among the ICU staff (12). Telemedicine coverage was
associated with decreased ICU mortality and LOS as reported
in a meta-analysis (13). Although many studies report improved
patient quality and outcomes due to telemedicine (10, 11, 13–
15), some studies have noted mixed and inconsistent benefits
and stark variations in the application of telemedicine (16–21).
Intricacy and variability in the application of telemedicine, along
with differences in study designs, creates a challenge to determine
the impact on quality and return on investment (22–25).
Although previous studies have reported challenges, advantages, and disadvantages of telemedicine implementation
(9, 15, 22, 26–31), there are no studies exploring effect of these
innovations on patient outcomes in PCUs. The main objective was to examine effects of telemedicine in PCU (TPCU)
on hospital mortality, LOS, and direct costs among PCU
patients using a retrospective observational study design at a
large healthcare system. Results from our study could provide
insights into association between telemedicine and patient
outcomes.

METHODS
Study Design and Population
This study was reviewed and approved by the institutional
review board. We performed a retrospective observational
study, with primary data collected from patients admitted
to PCUs between December 2011 and August 2016 across
five hospitals in South Florida region. Not all PCU beds
were equipped to receive telemedicine care; hence, patients
who did not receive telemedicine (nontelemedicine PCU
[NTPCU]) became suitable concurrent controls to those
patients who received telemedicine (TPCU) in same unit or
hospital. Hospital policies for those patients admitted or discharged to PCUs were based on American College of Critical
2
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Figure 1. Inclusion of patients into telemedicine progressive care unit
(PCU) (TPCU) and nontelemedicine PCU (NTPCU) groups.

Care Medicine guidelines (3). Inclusion criteria were all adult
patients admitted in PCUs as their primary admission without a prior ICU admission. All patients required a minimum
of 24 hours of PCU LOS to be included. If the encounter did
not reach these thresholds, patients were excluded. When
patients were downgraded to telemetry or med/surgical unit,
they were consequently discharged from TPCU, regardless of
bed availability. Patients were also excluded if demographics
information was missing (Fig. 1).
Measures
Demographic variables included age, gender, and race/ethnicity. Measures included admission diagnosis, PCU and hospital
LOS, PCU and hospital mortality, and the “total direct cost” of
hospitalization. Total direct cost is comprised of “direct fixed”
and “direct variable.” Direct fixed costs are for unit level operations, and the cost of telemedicine is reflected in direct fixed
costs per licensed bed per patient stay; “direct variable” includes
variable clinician staffing and patient care utilization costs.
We used the All Patient Refined-Diagnosis Related Group
(APR-DRG) disease severity and APR-DRG risk of mortality
(ROM) to stratify patients based on severity scores. Both APRDRG disease severity and APR-DRG ROM were categorized
into Minor (= 1), Moderate (= 2), Major (= 3), and Extreme
(= 4) (32). Hospital mortality was defined as death in hospital due to any cause. Hospital LOS was calculated as difference
between admission date and time and discharge date and time.
PCU LOS was calculated from the time acuity status order was
placed for each primary PCU stay until their status change
was placed. Age was categorized into 18–40, 41–65, 66–85, and
greater than and equal to 86 years. Race and ethnicity were categorized into White, Black, White Hispanic, Black Hispanic,
and Other. Mortality (PCU and hospital), LOS (PCU and hospital), and mean total direct costs were outcome measures.
Statistical Analyses
We used univariate, bivariate, chi-square, and independent
samples t test to describe the demographic characteristics, APRDRG disease severity, and APR-DRG ROM. Bivariate statistics
were also calculated for LOS and hospital mortality stratified by
XXX 2018 • Volume XX • Number XXX
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TPCU and NTPCU status. Survival analyses using a multivariate Cox proportional hazards model were conducted to calculate
hazard ratios (HRs) for hospital mortality. HR were adjusted for
hospital entity, demographics, organ systems, APR-DRG disease
severity, and APR-DRG ROM. Sensitivity analysis was performed
after randomly selecting 50% TPCU patients (n = 4,000) and
matching (1:1) these with NTPCU patients based on propensity
score. Propensity score was calculated from a logistic regression
model which included age, sex, race, APR-DRG disease severity,
and APR-DRG ROM. Up to 95% (or n = 3,800) TPCU patients
were matched 1:1 with the pool of control patients based on
their closest propensity score. In addition to propensity score
matching, HRs were calculated from this subsample after adjusting for hospital entities and Agency for Healthcare Research and
Quality clinical classification system (CCS) organ system categories in the model. Generalized linear mixed models were used
for estimating differences in direct costs between two groups.
For power and sample size calculation, it was hypothesized that
after 15 days of admission into PCU, at least 5% difference in HR
would be observed between two groups. A sample size of 7,993
in each group would be required to detect the difference at 90%
power and 5% level of significance. SAS software version 9.4
(SAS Institute Inc., Cary, NC) was used for statistical analyses.
Statistical significance was set at p value of less than 0.05.

RESULTS
Patient Characteristics
During the study period, 19,530 patients were admitted in the
PCUs (2011–2016). After excluding patients who did not meet
the study criteria, 16,091 patients were included in the study,
8,091 (50.3%) patients admitted to TPCU, and 8,000 (49.7%)
into NTPCU. The mean age of the participants admitted to
NTPCU and TPCU was 63.4 years (95% CI, 62.9–63.8 yr)
and 71.1 years (95% CI, 70.7–71.4 yr), respectively (Table 1).
Among patients admitted to TPCU, 50.6% were females,
63.5% were Hispanics, 25.7% Whites, and 7.1% Blacks. Among
those admitted to NTPCUs, 53.5% were females and 57.9%
were Hispanics, 27.6% Whites, and 10.5% Blacks. APR Disease Severity (p < 0.0001) and APR patient ROM (p < 0.0001)
scores were significantly different between patients admitted to
TPCU and NTPCU.
Mortality and LOS
During the study period, 60 patients (0.7%) died in TPCU,
compared with 83 patients (1%) in NTPCU (Table 1). The difference in proportion of patients who died in the TPCUs, compared with NTPCUs, was statistically significant (p = 0.048).
Hospital mortality rates were 4.4% for TPCUs and 5.2% for
NTPCUs, and the differences were statistically significant
(p = 0.013). Mean PCU LOS was higher among NTPCU
patients compared with TPCU (3.2 vs 2.6 d; p < 0.0001). PostPCU hospital LOS was longer for TPCU patients, compared
with NTPCU patients (7.3 vs 6.8 d; p < 0.0001). Unadjusted
Cox proportion survival analysis showed that patients admitted to TPCUs were 21% more likely to survive compared with
Critical Care Medicine

those admitted to NTPCUs (Fig. 2). After adjusting for age,
sex, race, APR-DRG disease severity, APR-DRG ROM, hospital entities, and organ systems, the survival benefit decreased
slightly to 20% (Table 2). Within each Clinical Classifications
Software (CCS) for International Classification of Diseases, 9th
Edition and International Classification of Diseases, 10th Edition categories, patients with diseases and disorders of the kidney and urinary tract (n = 679; HR, 0.40; 95% CI, 0.17–0.90;
p = 0.028), nervous system (n = 1435; HR, 0.50; 95% CI,
0.27–0.91; p = 0.023), and circulatory system (n = 4,601; HR,
0.69; 95% CI, 0.50–0.95; p = 0.021) showed the highest survival
benefit. Among five entities, highest survival benefit of 30%
was seen at the facility which was an urban community full
services hospital that were predominantly patients with cardiovascular and neurovascular illnesses in PCU. Sensitivity analysis
was performed on a pool of 7,600 propensity score matched
patients (3,800 in each group). Results from the sensitivity analysis showed that after accounting for age, sex, race, APR-DRG
disease severity, APR-DRG ROM, hospital entities, and organ
systems, patients in TPCU group were 44% (24–59%) more
likely to survive compared with NTPCU patients.
Cost of Telemedicine in PCUs
The overall mean direct costs were higher for patients admitted to TPCUs, compared with NTPCUs ($13,180 vs $12,301;
p < 0.0001) (Table 3). Mean direct costs were higher for TPCUs
in the age groups, 18–40, 41–65, and 66–85 years (p < 0.0001),
but among greater than and equal to 86 years age group, it was
higher for NTPCU group. TPCU patients with APR-DRG disease severity scores of major (p < 0.001) and extreme (p < 0.01)
had significantly higher mean direct costs than patients did in
NTPCU. Similarly, mean direct costs for patients with APRDRG ROM scores of major (p < 0.01) and extreme (p < 0.01)
were significantly higher in patents admitted to TPCU when
compared with NTPCUs. Patients with nervous, respiratory,
and musculoskeletal system disorders, and diagnosis of pregnancy and childbirth in TPCU had higher mean direct costs;
and in NTPCU group, it was higher among patients with endocrine and metabolic disorders.

DISCUSSION
Although there are many studies about the effects of Tele-ICU,
currently, to the best of our knowledge, this is the first study
to examine the impact of telemedicine on mortality, LOS, and
direct costs in patients with PCU (TPCU) admissions. The ICU
admission, discharge, and triage guidelines set forth by Nates
et al (3) and endorsed by the Society of Critical Care Medicine recommend patients with high severity of illness, multiple
comorbidities, and need for organ support be cared for in a
“step-down unit.” These types of units are variably referred to
as “high dependency, intermediate, or transitional care units.”
The label PCU has been applied to encompass all the variations.
Just as varied as the labels are the configurations and capabilities across healthcare settings. Little formal investigation
exists to describe and evaluate the effectiveness of PCUs (3).
It is hypothesized that ICU services, bed utilization, and patient
www.ccmjournal.org
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TABLE 1. Characteristics of Telemedicine Progressive Care Unit and Nontelemedicine
Progressive Care Unit Patients (n = 16,091)

Characteristics

Age (yr), mean (95% CI)

Nontelemedicine
Progressive Care Unit
(n = 8,000)

Telemedicine
Progressive Care
Unit (n = 8,091)

p

63.4 (62.9–63.8)

71.1 (70.7–71.4)

< 0.0001

18–40

964 (12.3)

441 (5.5)

< 0.0001

41–65

2,437 (31.2)

2,000 (24.7)

66–85

3,392 (43.4)

4,033 (49.8)

≥ 86

1,018 (13.0)

1,617 (10.0)

Male

3,724 (46.5)

4,000 (49.4)

Female

4,276 (53.5)

4,091 (50.6)

White

2,206 (27.6)

2,077 (25.7)

Black

843 (10.5)

Age groups, n (%)

Gender, n (%)
< 0.001

Race, n (%)

White Hispanic
Black Hispanic

577 (7.1)

4,541 (56.8)

5,060 (62.5)

87 (1.1)

75 (1.0)

323 (4.0)

301 (3.7)

Minor = 1

1,214 (15.2)

671 (8.3)

Moderate = 2

2,145 (26.9)

2,243 (27.8)

Major = 3

3,123 (39.1)

3,615 (44.7)

Extreme = 4

1,502 (18.8)

1,548 (19.2)

Minor = 1

2,401 (30.1)

1,408 (17.4)

Moderate = 2

1,786 (22.3)

2,154 (26.7)

Major = 3

2,419 (30.3)

2,980 (36.9)

Extreme = 4

1,378 (17.3)

1,535 (19.0)

Other

< 0.0001

APR-DRG severity of illness, n (%)
< 0.0001

APR-DRG risk of mortality, n (%)
< 0.0001

Deaths, n (%)
PCU
Hospital

83 (1.0)

60 (0.7)

0.048

410 (5.2)

342 (4.4)

0.013

Length of stay, mean (95% CI)
PCU

3.2 (3.1–3.3)

2.6 (2.5–2.7)

< 0.0001

Hospital

6.8 (6.6–6.9)

7.3 (7.2–7.5)

< 0.0001

APR-DRG = All Patient Refined-Diagnosis Related Group, PCU = progressive care unit.

care outcomes may be positively impacted through use of
PCUs (4, 33–35); similarly Tele-ICU has shown to impact these
factors positively (10, 11, 13–15, 36) and therefore, Tele-PCU
may also provide a distinct advantage. We found that PCU and
hospital mortality rates were significantly lower for patients in
TPCU group, compared with patients in NTPCUs. PCU LOS
4
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was also significantly lower for TPCU patients, compared with
NTPCU patients. We found that mean post-PCU hospital LOS
and total mean direct cost were higher for patients admitted to
TPCUs that coincided with improved survival.
Several reasons PCUs were established or became part
of the hospital system are because studies indicated that a
XXX 2018 • Volume XX • Number XXX
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Figure 2. Survival curves for Cox proportional hazards model with
telemedicine at progressive care unit (PCU) (TPCU) admission (solid
line) and without telemedicine at PCU (NTPCU) admission (dotted line).
LOS = length of stay.

significant proportion of adult ICU occupancies were lower
severity patients admitted for monitoring rather than active
treatment (37). Often these patients were admitted postoperatively for observation and had very small mortality rates of
0.03 with short ICU and hospital LOS (2). Solberg et al (38)
concluded that the introduction of PCU has increased the
operational efficiency of the ICU with fewer low risk patients
being admitted. A recent prospective multinational European
study demonstrated that adults admitted to ICUs of hospitals
with an intermediate care unit (IMCU) have significantly lower
adjusted hospital mortality 0.63 (95% CI, 0.45–0.88; p = 0.007)
than those admitted to ICUs of hospitals without an IMCU
after severity and characteristics adjustments (39). Closures of
PCUs also seemed to have a negative impact on the ICUs (39).
However, further evidence is required to cement the view that
PCUs lead to improved patient outcomes and optimal healthcare delivery (6, 40).
Similar to our findings, previous studies conducted in
ICU settings have shown that Tele-ICU was associated with
improved patient outcomes. For example, in a prospective
stepped-wedge clinical practice study, installation of TeleICU was associated with decreased mortality and hospital
LOS (10). This was attributed to improved adherence to best
practices in critical care such as prevention of venous thrombosis, cardiovascular complications, ventilator associated

pneumonia, stress ulcers, timely administration of antimicrobial medications, and resuscitation procedures (10).
Improvements in clinical outcomes due to Tele-ICU implementation in ICUs were also observed in a large scale study
involving more than 24,000 patients (41). This study demonstrated a decrease in severity-adjusted ICU LOS, along with
a decrease of 0.77 in relative risk of hospital mortality (41).
Probable mechanisms for this improvement include greater
levels of participation of the Tele-ICU team in implementing
patient care and improved coordination with bedside caregivers (41). In another study, it was observed that severityadjusted ICU LOS significantly improved from 0.84 to –0.03
(or 4,772 saved ICU days; p < 0.001) and severity-adjusted
hospital LOS improved from 0.97 to –0.64 (or 6,091 saved
floor days; p = 0.001) (42). In a study evaluating 15 rural multistate ICUs, Tele-ICU implementation was associated with
lower mortality and LOS in ICUs (21). A meta-analysis of
13 studies involving 35 ICUs showed similar findings where
Tele-ICU implementation was associated with lower ICU
mortality rates and LOS; there was no effect of Tele-ICU outside of ICU on hospital mortality rates or hospital LOS (13).
While implementing TPCUs, both costs and patient outcome characteristics should be considered. Previous studies
in this field revealed considerable variability concerning the
benefits to mortality or LOS after Tele-ICU implementation
in relationship to cost (43, 44). For example, an observational
study of 4,142 ICU patients reported 24% increase in daily
hospital costs, 43% increase in cost per case, and 28% increase
in cost per patient (44). A retrospective study using administrative database from 106 adult ICU beds showed that capital costs for telemedicine units were $1,186,220 and annual
operational costs were $1,250,112, thus accounting to $23,150
per telemedicine unit (43). Benefits to mortality or LOS after
Tele-ICU implementation may be associated with increased
cost; however, it has also been noted the initial costs in establishing and operating TPCUs may be reclaimed over the years
through cost savings due to favorable patient outcomes (23,
24, 45, 46). The conduct of Tele-ICU cost analyses has been
recognized as an “imperfect science,” (47) requires “alternative research designs,” (48) and is an “analyses of a complex
intervention.” (24)
For our study, the total enterprise-wide annual operation
cost for telemedicine was equally distributed across the organization as a cost per licensed bed per patient unit stay. This

Cox Proportional Survival Analysis With Unadjusted and Adjusted Hazard Ratios
for Hospital Mortality in Telemedicine Progressive Care Unit (n = 16,091)
TABLE 2.

Adjusted
Survival Analysis

Hazard ratios (95% CI)a

Unadjusted

Model 1b

Model 2c

Model 3d

0.79 (0.68–0.91)

0.71 (0.61–0.82)

0.80 (0.67–0.96)

0.56 (0.41–0.76)

Reference: progressive care unit patients without telemedicine.
b
Model 1: age, sex, and race.
c
Model 2: age, sex, and race, All Patient Refined-Diagnosis Related Group (APR-DRG) severity of illness, APR-DRG risk of mortality, hospital entity, and organ
systems.
d
Model 3: propensity score matched on age, sex, and race, APR-DRG severity of illness, APR-DRG risk of mortality (n = 7,600).
a

Critical Care Medicine
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TABLE 3. Mean (95% CI) Direct Costs Associated With Patient Admissions Stratified by
Telemedicine Progressive Care Unit and Nontelemedicine Progressive Care Unit
(in U.S. Dollars; n = 16,091)
Category

Characteristics

Overall
Age groups

Gender
Race

APR severity
of illness

APR risk
of mortality

Primary admission
diagnosis
classified by
organ system

18–40

Nontelemedicine
Progressive Care Unit

Telemedicine
Progressive Care Unit

p

12,301 (12,100–12,501)

13,180 (12,941–13,420)

< 0.0001

11,685 (11,093–12,277)

12,329 (11,219–13,439)

0.3

41–65

13,181 (12,785–13,577)

13,479 (12,985–13,973)

0.35

66–85

13,162 (12,832–13,492)

14,122 (13,776–14,467)

< 0.0001

≥ 86

11,792 (11,265–12,318)

12,540 (12,062–13,017)

0.04

Male

13,041 (12,702–13,379)

14,010 (13,652–14,369)

< 0.0001

Female

12,334 (12,069–12,599)

13,098 (12,779–13,416)

< 0.001

White

13,121 (12,723–13,519)

13,992 (13,522–14,462)

< 0.005

Black

11,974 (11,267–12,681)

15,080 (14,072–16,089)

< 0.0001

White Hispanic

12,548 (12,271–12,824)

13,220 (12,920–13,519)

< 0.01

Black Hispanic

9,915 (8,378–11,452)

13,864 (11,725–16,002)

< 0.003

Other

13,695 (12,524–14,866)

13,016 (11,754–14,278)

0.44

Minor = 1

10,039 (9,730–10,347)

9,818 (9,182–10,455)

0.54

Moderate = 2

10,380 (10,631–10,698)

10,666 (10,298–11,035)

0.25

Major = 3

12,319 (12,010–12,627)

13,138 (12,826–13,450)

< 0.001

Extreme = 4

18,760 (18,082–19,438)

20,303 (19,585–21,020)

< 0.01

Minor = 1

10,247 (10,002–10,492)

10,493 (10,039–10,947)

0.35

Moderate = 2

11,872 (11,442–12,302)

11,583 (11,207–11,959)

0.32

Major = 3

12,997 (12,622–13,371)

13,718 (13,344–14,093)

< 0.01

Extreme = 4

17,313 (16,612–18,013)

18,783 (18,070–19,495)

< 0.004

Circulatory system

12,980 (12,464–13,495)

13,301 (12,876–13,725)

0.35

Nervous system

10,649 (9,832–11,466)

12,378 (11,792–12,965)

< 0.001

Respiratory system

11,334 (10,962–11,706)

12,707 (12,119–13,296)

< 0.0001

Gastrointestinal system

13,446 (12,893–13,999)

12,808 (12,159–13,458)

0.14

Infectious diseases

14,309 (13,515–15,103)

15,001 (14,139–15,864)

0.24

Musculoskeletal system

16,277 (15,398–17,156)

19,047 (18,102–19,991)

< 0.001

Renal and urinary tract

11,516 (10,702–12,330)

12,335 (11,315–13,356)

0.21

Endocrine/metabolic
disorders

10,935 (10,644–11,227)

9,179 (7,862–10,496)

< 0.0001

Blood disorders

17,482 (15,759–19,204)

16,130 (14,000–18,260)

0.34

Pregnancy and childbirth

9,306 (8,402–10,210)

12,255 (10,273–14,236)

0.0025

Injuries, toxins, and poisonings

9,395 (6,821–11,968)

9,293 (6,639–11,947)

0.95

Ear, nose, mouth, and throat

8,385 (6,442–10,328)

8,377 (6,417–10,338)

0.99

Alcohol and drug use

5,224 (4,140–6,309)

6,215 (4,353–8,076)

0.4

Male reproductive system

9,831 (8,749–10,913)

12,036 (7,077–16,994)

Mental disorders

0.38

7,672 (3,859–11,484)

6,839 (2,818–10,860)

0.73

Progressive care
unit LOS (d)

<2

10,441 (10,171–10,711)

11,276 (10,976–11,576)

< 0.0001

≥2

14,600 (14,293–14,907)

15,986 (15,622–16,349)

< 0.0001

Hospital LOS (d)

<5

8,357 (8,161–8,552)

≥5

16,322 (16,006–16,638)

8,057 (7,818–8,296)
17,035 (16,709–17,361)

< 0.06
< 0.002

APR = All Patient Refined, LOS = length of stay.
Boldface font indicates significance p value.
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cost was reflected in the “direct fixed” within the “total direct
costs.” Because we wished to ascertain the exact added cost of
telemedicine, inclusion of the “direct fixed” within the “total
direct costs” was necessary. This turned out to be an advantage
as we have accounted for both “direct variable” (direct patient
care utilization) and “direct fixed” (cost of TPCU and cost of
PCU level care). We believe inclusion of PCU level operational
costs may be considered relevant for examination of the overall
cost of care delivery. PCU cost of care delivery is fundamentally
lower than that of ICU and higher than telemetry or med/surg.
The cost of TPCU added to PCU is another layer of additional
costs. However, our study demonstrated, despite the additional
cost of TPCU, the total mean direct costs in the TPCU group
only increased by a nominal amount of 300 dollars per patient
per day when the estimated TPCU cost was $650 per patient
per unit stay more than NTPCU in this healthcare system.
Yoo et al (25) compared Tele-ICU to non-Tele-ICU cost
effectiveness through probabilistic analyses conducted on
available literature to calculate incremental cost effectiveness
ratios and quality-adjusted life years over a 5-year span. Yoo
et al (25) calculated weighted averages from studies reporting both favorable and unfavorable costs/benefit ratios. Their
resultant comparison for with and without tele models was
comprised of the product of cost(s) multiplied by reported
benefits available in literature to create impact ratios (0.94;
0.71–1.14) for ICU and (1.02; 0.80–1.30) for floor post-ICU
for alive patients (25). Combining the mean estimated costs for
ICU and post-ICU plus tele-operational costs, the difference
between total hospital cost with Tele-ICU and without was
only 304 dollars per patient per hospital stay. To the extent that
Yoo et al (25) data provide valid results as they are constructed
upon the extant literature beleaguered with inherent variability and theoretical assumptions, our results based on primary
data are in agreement with the direction of their hypothetical
results.
Our study has some limitations. The current study was conducted on retrospective data and had limitations of an observational study design. The lack of ability to control for clinician
selection of telemedicine intervention in PCU or the lack of
technologically equipped bed availability in some locations is
inherent in this study. The PCU bed configuration is complex
in this health system and likely complex in other organizations
based on available literature (3). Our system is mixture of beds
and/or units with TPCU and NTPCU; therefore, selection
bias may be of concern. Although each entity had both TPCU
monitored and NTPCU beds under various configurations, all
other services provided and staffing were considered relatively
equal within entity and units. Additionally, majority of our
patients were of Hispanic ethnicity, which is not representative
of the general population.
The main strengths of our study were large sample size, rigorous analytical procedures, severity adjustments, and homogenous TPCU and NTPCU patient characteristics. Despite
older and more severely ill patient population in TPCU group,
we found statistically significant benefits. The circumstances of
this study that not all PCU beds or units were equipped with
Critical Care Medicine

TPCU capability, which created a suitable concurrent control
group and propensity score matched analysis, may have minimized this selection bias. In addition to this, pooling data from
five different hospitals allowed us to minimize selection bias.
Furthermore, there were equal distribution of deaths among
the PCU sites based on their bed capacity. Although the use
of TPCU versus NTPCU was driven by both availability and
clinical judgment, PCU designation is based on acuity and was
severity adjusted in this study. PCU is not only a relevant strategy to reduce ICU LOS and readmissions and optimize ICU
bed utilization, it serves the needs of many patients that do not
require ICU level care but are at a high risk of deterioration.
Tele-ICU innovation has improved ICU treatment in critical care, have reduced ICU mortality and ICU LOS based on
numerous studies. Using these evidences, we can theorize on
the efficiency and role in reducing morbidity and mortality in
the PCU if a TPCU intervention approach is used.

CONCLUSIONS
Although there are many studies about the effects of telemedicine in ICU, currently there are no studies on the effects of
telemedicine in PCU settings. Our study showed that TPCU
intervention significantly decreased mortality in PCU and
hospital and PCU LOS despite the fact patients in TPCU were
older and had higher disease severity, and ROM. Increased
post-PCU hospital LOS and total mean direct costs inclusive
of telemedicine costs coincided with improved survival rates.
Evidence from our study suggests that Telemedicine decreases
overall mortality and LOS within PCU without substantial cost
incurrences.
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